Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease-Reference-Cited by-同舟云学术

Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease

Published:2016-01-04 Issue:4 Volume:51 Page:542-545
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Egan G,Cervone K A,Philips P C,Belasco J B,Finlay J L,Gardner S L

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2015313.pdf

Reference28 articles.

1. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 2013; 15 Suppl 2: ii1–56.

2. Goldwein JW, Glauser TA, Packer RJ, Finlay JL, Sutton LN, Curran WJ et al. Recurrent intracranial ependymomas in children. Survival, patterns of failure and prognostic factors. Cancer 1990; 66: 557–563.

3. Lefkowitz IB, Packer RJ, Siegel KR, Sutton LN, Schut L, Evans AE . Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine. Cancer 1990; 65: 412–417.

4. Dunkel IJ, Boyett JM, Yates A, Rosenblum M, Garvin JH Jr, Bostrom BC et al. High dose carboplatin, thiotepa and etoposide with autologous stem cell rescue for patients with recurrent medulloblastoma. J Clin Oncol 1998; 16: 222–228.

5. Finlay JL, Dhall G, Boyett JM, Dunkel IJ, Gardner SL, Goldman S et al. Myeloablative chemotherapy with auloglous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2008; 51: 806–811.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective re-induction regimen for children with recurrent medulloblastoma;Neuro-Oncology Advances;2024-01-01

2. Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment;Cancers;2021-12-28

3. Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments;Frontiers in Pharmacology;2021-05-18

4. Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study;Pediatric Blood & Cancer;2019-10-08

5. Clinical Characteristics and Outcome of Children With Relapsed Medulloblastoma: A Retrospective Study at a Single Center in China;Journal of Pediatric Hematology/Oncology;2018-11